The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway
Xinyi Wu(University of North Carolina at Chapel Hill), Charles L. Sawyers(Memorial Sloan Kettering Cancer Center)
Cited by 691
Related Papers
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency
|Journal of Clinical Investigation|2007|415
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
|eLife|2017|215
GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
|eLife|2019|24
Timing of treatment shapes the path to androgen receptor signaling inhibitor resistance in prostate cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1
BRCA2 reversion mutation-independent resistance to PARP inhibition in prostate cancer through loss of function perturbations in the DNA pre-replication complex
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1